May 2016 – Published in Contemporary OB/GYN, this supplement captured proceedings of a panel discussion hosted by Sera Prognostics at the 2016 Society of Maternal-Fetal Medicine Annual meeting.

Today, with the tools available, physicians are unable to predict the large majority of women who will eventually deliver early. Now there is a proteomic predictor—the PreTRM test—which also provides the beginning of greater understanding of pathways.

Objectives of this discussion were to look at some of the implications of having an objective predictor, the PreTRM test, for early prediction of preterm birth risk. What do we do differently? In what ways can this make a greater difference in the fight against preterm birth? And address some of the uncertainties that exist when physicians know a woman is at risk for preterm birth.